NIH's Dr. Carl Dieffenbach Discusses HIV Treatment Science at 2016 Ryan White Conference

From AIDS.gov

August 26, 2016

____________________________________________________________________________________ 

As the 2016 National Ryan White Conference on HIV Care and Treatment wound down in Washington, D.C., NIH's Dr. Carl Dieffenbach and his colleague Anne Rancourt joined us for a conversation on Facebook Live about HIV treatment. They discussed what scientists now know about the benefits of HIV treatment and when people diagnosed with HIV should begin treatment.

Dr. Dieffenbach and Ms. Rancourt also discussed how the Ryan White HIV/AIDS Program as well as some jurisdictions are making big strides in improving outcomes along the HIV care continuum, increasing the proportion of individuals living with HIV who are in care, on treatment, and with a suppressed viral load. They also highlighted some ongoing NIH-supported research on HIV treatment. These include studies aimed at developing long-acting formulations of antiretroviral therapy (ART). In addition, NIH is supporting studies that address comorbidities that people living with HIV are experiencing as they live longer lives because of effective HIV treatment. One example is the REPREIVE Trial, which is studying how to prevent heart disease among people living with HIV.

View their conversation here. You can also view other videos and more coverage from the 2016 Ryan White Conference on AIDS.gov's Facebook page.

Anne Rancourt sat down with 

NIH’s Dr. Carl Dieffenbach to

 talk about treatment and care of PLWH 

on the last day of Ryan White 2016 

Related Stories

2016 National Ryan White Conference on HIV Care and Treatment: Day Three Recap

2016 National Ryan White Conference on HIV Care and Treatment: Day Two Recap

2016 National Ryan White Conference on HIV Care and Treatment: Day One Recap Read more articles from The Body Pro, here.